CNBD2
gene geneOn this page
Also known as dJ954P9.1
Summary
CNBD2 (cyclic nucleotide binding domain containing 2, HGNC:16145) is a protein-coding gene on chromosome 20q11.23, encoding Cyclic nucleotide-binding domain-containing protein 2 (Q96M20). Essential for male fertility.
Predicted to enable cAMP binding activity. Predicted to be involved in spermatogenesis. Predicted to be located in cytosol.
Source: NCBI Gene 140894 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 121 total
- MANE Select transcript:
NM_001365709
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16145 |
| Approved symbol | CNBD2 |
| Name | cyclic nucleotide binding domain containing 2 |
| Location | 20q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ954P9.1 |
| Ensembl gene | ENSG00000149646 |
| Ensembl biotype | protein_coding |
| Entrez | 140894 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 nonsense_mediated_decay
ENST00000349339, ENST00000373973, ENST00000463258, ENST00000489667, ENST00000538900, ENST00000614708, ENST00000622112
RefSeq mRNA: 4 — MANE Select: NM_001365709
NM_001207076, NM_001304367, NM_001365709, NM_080834
CCDS: CCDS13270, CCDS56189, CCDS77575, CCDS93033
Canonical transcript exons
ENST00000373973 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000991766 | 36008297 | 36008474 |
| ENSE00000991767 | 36011137 | 36011257 |
| ENSE00000991770 | 35972629 | 35972766 |
| ENSE00000991771 | 35975949 | 35976002 |
| ENSE00000991772 | 35980459 | 35980622 |
| ENSE00000991773 | 35983982 | 35984138 |
| ENSE00000991774 | 35984627 | 35984778 |
| ENSE00000991775 | 35987395 | 35987533 |
| ENSE00000991776 | 35995038 | 35995152 |
| ENSE00001147260 | 36023602 | 36023771 |
| ENSE00001856023 | 35968590 | 35968813 |
| ENSE00003512577 | 36030357 | 36030700 |
Expression profiles
Bgee: expression breadth ubiquitous, 181 present calls, max score 93.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.4662 / max 85.6525, expressed in 1405 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 184342 | 2.7938 | 1274 |
| 184341 | 0.6528 | 280 |
| 184343 | 0.0197 | 4 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 93.51 | gold quality |
| right testis | UBERON:0004534 | 87.52 | gold quality |
| left testis | UBERON:0004533 | 87.40 | gold quality |
| testis | UBERON:0000473 | 85.31 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 84.71 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 83.52 | silver quality |
| gastrocnemius | UBERON:0001388 | 83.44 | gold quality |
| muscle of leg | UBERON:0001383 | 83.23 | gold quality |
| quadriceps femoris | UBERON:0001377 | 83.03 | silver quality |
| vastus lateralis | UBERON:0001379 | 82.70 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.51 | gold quality |
| biceps brachii | UBERON:0001507 | 80.38 | silver quality |
| deltoid | UBERON:0001476 | 79.36 | silver quality |
| granulocyte | CL:0000094 | 77.88 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 77.14 | gold quality |
| kidney epithelium | UBERON:0004819 | 76.95 | gold quality |
| islet of Langerhans | UBERON:0000006 | 76.88 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 75.97 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 75.55 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 75.44 | gold quality |
| cerebellar cortex | UBERON:0002129 | 75.13 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 74.97 | gold quality |
| muscle tissue | UBERON:0002385 | 74.78 | gold quality |
| monocyte | CL:0000576 | 74.42 | gold quality |
| metanephros cortex | UBERON:0010533 | 74.25 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 74.09 | silver quality |
| right lobe of liver | UBERON:0001114 | 73.60 | gold quality |
| cerebellum | UBERON:0002037 | 73.41 | gold quality |
| leukocyte | CL:0000738 | 73.36 | gold quality |
| mucosa of stomach | UBERON:0001199 | 73.34 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.62 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cnbd2 | ENSMUSG00000038085 |
| rattus_norvegicus | Cnbd2 | ENSRNOG00000019992 |
| drosophila_melanogaster | CG12698 | FBGN0030721 |
| drosophila_melanogaster | CG8958 | FBGN0030725 |
| drosophila_melanogaster | CG14693 | FBGN0037837 |
Protein
Protein identifiers
Cyclic nucleotide-binding domain-containing protein 2 — Q96M20 (reviewed: Q96M20)
All UniProt accessions (5): Q96M20, A0A087WUQ5, A0A087WVB8, Q4G141, U3KQM1
UniProt curated annotations — full annotation on UniProt →
Function. Essential for male fertility. Plays an important role in spermatogenesis and regulates sperm motility by controlling the development of the flagellar bending of sperm.
Subcellular location. Cytoplasm. Cytosol.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96M20-1 | 1 | yes |
| Q96M20-2 | 2 | |
| Q96M20-3 | 3 |
RefSeq proteins (4): NP_001194005, NP_001291296, NP_001352638, NP_543024 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000595 | cNMP-bd_dom | Domain |
| IPR014710 | RmlC-like_jellyroll | Homologous_superfamily |
| IPR018488 | cNMP-bd_CS | Conserved_site |
| IPR018490 | cNMP-bd_dom_sf | Homologous_superfamily |
Pfam: PF00027
UniProt features (7 total): sequence variant 3, splice variant 2, chain 1, binding site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96M20-F1 | 69.79 | 0.20 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (1): 116–239
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 92 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, GOBP_MALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, chr20q11, MODULE_48, MODULE_95, GOCC_MOTILE_CILIUM, GOCC_SPERM_MIDPIECE, GOCC_CILIUM, GOMF_CAMP_BINDING, STAT5A_02, GOMF_CYCLIC_NUCLEOTIDE_BINDING
GO Biological Process (1): spermatogenesis (GO:0007283)
GO Molecular Function (2): cAMP binding (GO:0030552), nucleotide binding (GO:0000166)
GO Cellular Component (2): cytosol (GO:0005829), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cyclic nucleotide binding | 1 |
| adenyl ribonucleotide binding | 1 |
| anion binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| cytoplasm | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
1378 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CNBD2 | KIAA1191 | Q96A73 | 585 |
| CNBD2 | IQCF1 | Q8N6M8 | 531 |
| CNBD2 | CNBD1 | Q8NA66 | 521 |
| CNBD2 | EPB41L1 | Q9H4G0 | 491 |
| CNBD2 | TOPAZ1 | Q8N9V7 | 449 |
| CNBD2 | C14orf39 | Q8N1H7 | 432 |
| CNBD2 | KLHDC3 | Q9BQ90 | 429 |
| CNBD2 | SPEM1 | Q8N4L4 | 417 |
| CNBD2 | DNAAF6 | Q9NQM4 | 411 |
| CNBD2 | KLHL10 | Q6JEL2 | 407 |
| CNBD2 | SLC71A1 | Q96MC6 | 406 |
| CNBD2 | TERB1 | Q8NA31 | 387 |
| CNBD2 | SPATA22 | Q8NHS9 | 381 |
| CNBD2 | IFTAP | Q86VG3 | 377 |
| CNBD2 | SYCE3 | A1L190 | 375 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A2ARP1, A2BID5, A7Z050, B6ZK77, O00750, O14976, O70344, O75460, P0C644, P16386, P19687, P35523, P35524, P54310, P70606, P97874, Q08CH3, Q0IH22, Q0P5V9, Q1LXZ7, Q3TRM4, Q5RDF1, Q640M6, Q64347, Q68J42, Q6IRN0, Q6JWV8, Q6P4K6, Q6P6V6, Q6PFW1, Q6R5J1, Q6ZN44, Q86VS3, Q8IZJ1, Q91WF3, Q95JR6, Q96M20, Q99KY4, Q9D2K4, Q9D5U8
Diamond homologs: Q95JR6, Q96M20, Q9D5U8, Q2K5E1, Q5SID7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
121 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 101 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2099 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:35972739:G:GT | donor_gain | 1.0000 |
| 20:35972739:G:T | donor_gain | 1.0000 |
| 20:35972762:GGGAT:G | donor_gain | 1.0000 |
| 20:35972763:GGAT:G | donor_gain | 1.0000 |
| 20:35972763:GGATG:G | donor_gain | 1.0000 |
| 20:35972764:G:T | donor_gain | 1.0000 |
| 20:35972764:GAT:G | donor_gain | 1.0000 |
| 20:35972764:GATG:G | donor_gain | 1.0000 |
| 20:35972767:G:GG | donor_gain | 1.0000 |
| 20:35976000:G:GT | donor_gain | 1.0000 |
| 20:35980627:G:GG | donor_gain | 1.0000 |
| 20:35984618:A:AG | acceptor_gain | 1.0000 |
| 20:35984619:C:G | acceptor_gain | 1.0000 |
| 20:35984622:A:AG | acceptor_gain | 1.0000 |
| 20:35984625:A:AG | acceptor_gain | 1.0000 |
| 20:35984625:AG:A | acceptor_gain | 1.0000 |
| 20:35984626:G:GT | acceptor_gain | 1.0000 |
| 20:35984626:GG:G | acceptor_gain | 1.0000 |
| 20:35984626:GGA:G | acceptor_gain | 1.0000 |
| 20:35984626:GGAA:G | acceptor_gain | 1.0000 |
| 20:35984626:GGAAA:G | acceptor_gain | 1.0000 |
| 20:35984738:G:GT | donor_gain | 1.0000 |
| 20:35984750:G:GT | donor_gain | 1.0000 |
| 20:35984754:C:G | donor_gain | 1.0000 |
| 20:35984758:G:GG | donor_gain | 1.0000 |
| 20:35984775:TTAGG:T | donor_loss | 1.0000 |
| 20:35984778:GG:G | donor_loss | 1.0000 |
| 20:35984779:GT:G | donor_loss | 1.0000 |
| 20:35987503:A:T | donor_gain | 1.0000 |
| 20:36008475:G:GG | donor_gain | 1.0000 |
AlphaMissense
3846 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:35980512:A:C | R99S | 0.992 |
| 20:35980512:A:T | R99S | 0.992 |
| 20:36023662:A:C | S444R | 0.988 |
| 20:36023664:C:A | S444R | 0.988 |
| 20:36023664:C:G | S444R | 0.988 |
| 20:35984674:T:G | C204W | 0.987 |
| 20:35980511:G:C | R99T | 0.982 |
| 20:35984050:G:T | G159V | 0.978 |
| 20:35983996:G:C | R141P | 0.976 |
| 20:35984672:T:C | C204R | 0.976 |
| 20:35984056:T:A | V161D | 0.974 |
| 20:35984058:G:C | A162P | 0.973 |
| 20:35984049:G:C | G159R | 0.972 |
| 20:35995054:T:C | L291P | 0.970 |
| 20:35995057:G:C | R292P | 0.970 |
| 20:35984673:G:A | C204Y | 0.968 |
| 20:35984700:T:A | V213D | 0.966 |
| 20:35984091:T:C | F173L | 0.965 |
| 20:35984093:C:A | F173L | 0.965 |
| 20:35984093:C:G | F173L | 0.965 |
| 20:35984694:T:C | L211P | 0.962 |
| 20:36030419:T:C | L501P | 0.961 |
| 20:35980601:C:A | A129D | 0.958 |
| 20:35975973:T:C | F72L | 0.957 |
| 20:35975975:T:A | F72L | 0.957 |
| 20:35975975:T:G | F72L | 0.957 |
| 20:35980613:G:C | R133P | 0.956 |
| 20:35984050:G:A | G159D | 0.956 |
| 20:35984670:T:A | V203D | 0.954 |
| 20:36030410:G:C | R498P | 0.954 |
dbSNP variants (sampled 300 via entrez): RS1000006990 (20:36022144 G>A), RS1000040268 (20:35980312 G>A), RS1000060955 (20:36021806 G>T), RS1000090579 (20:35980597 C>T), RS1000124315 (20:35968760 A>G), RS1000163432 (20:35991668 G>C), RS1000274054 (20:35988030 C>T), RS1000306965 (20:36003690 G>A), RS1000318870 (20:35973719 G>A,T), RS1000397450 (20:35976206 T>C), RS1000417733 (20:35954855 C>A,T), RS1000438496 (20:35995699 T>G), RS1000512727 (20:36009548 C>G), RS1000532386 (20:35955180 C>G,T), RS1000533295 (20:36002835 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_66 | Refractive error | 2.000000e-20 |
| GCST012227_1149 | Hip circumference adjusted for BMI | 3.000000e-17 |
| GCST90000025_646 | Appendicular lean mass | 8.000000e-22 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008039 | BMI-adjusted hip circumference |
| EFO:0004980 | appendicular lean mass |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression | 2 |
| aflatoxin B2 | decreases methylation | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Niclosamide | increases expression | 1 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.